Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. (Q50928395)

From Wikidata
Jump to navigation Jump to search
scientific article published on 25 September 2015
edit
Language Label Description Also known as
English
Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma.
scientific article published on 25 September 2015

    Statements

    Combined circulating epigenetic markers to improve mesothelin performance in the diagnosis of malignant mesothelioma. (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit